focus
Previous article:
BioMarin wins approval for gene therapy to treat hemophilia A
Next article: Churchill Downs extends trainer Bob Baffert's ban through 2024
Next article: Churchill Downs extends trainer Bob Baffert's ban through 2024
explore
hotspot
-
JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK
2025-08-23 08:45 -
Rune Labs, whose app tracks Parkinson's symptoms, raises $12M
2025-08-23 08:21 -
Medicare Advantage overpayments discussion gets experts fired up
2025-08-23 08:19 -
Life science postdocs should get big pay hike, NIH panel says
2025-08-23 07:57 -
Study suggests new cause of Down syndrome: cells linked to aging
2025-08-23 07:30 -
Stories you might have missed in 2023: health, science, medicine
2025-08-23 06:55